Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Acute lymphoblastic leukaemia.

Pui CH, Robison LL, Look AT.

Lancet. 2008 Mar 22;371(9617):1030-43. doi: 10.1016/S0140-6736(08)60457-2. Review.

PMID:
18358930
2.

Recent advances in the treatment and understanding of childhood acute lymphoblastic leukaemia.

Rubnitz JE, Pui CH.

Cancer Treat Rev. 2003 Feb;29(1):31-44. Review.

PMID:
12633578
3.

[A brief history of treatments for childhood acute lymphoblastic leukaemia].

Leverger G, Baruchel A, Schaison G.

Bull Acad Natl Med. 2009 Oct;193(7):1495-9; discussion 1499-500. French.

PMID:
20669630
4.

Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period [corrected].

Magrath I, Shanta V, Advani S, Adde M, Arya LS, Banavali S, Bhargava M, Bhatia K, Gutiérrez M, Liewehr D, Pai S, Sagar TG, Venzon D, Raina V.

Eur J Cancer. 2005 Jul;41(11):1570-83. Epub 2005 Jan 5. Review. Erratum in: Eur J Cancer. 2007 Feb;43(3):632. Raina, V [added].

PMID:
16026693
5.

Acute lymphoblastic leukaemia.

Inaba H, Greaves M, Mullighan CG.

Lancet. 2013 Jun 1;381(9881):1943-55. doi: 10.1016/S0140-6736(12)62187-4. Epub 2013 Mar 22. Review.

6.

New therapeutic strategies for the treatment of acute lymphoblastic leukaemia.

Pui CH, Jeha S.

Nat Rev Drug Discov. 2007 Feb;6(2):149-65. Review.

PMID:
17268486
7.

Relapsed childhood acute lymphoblastic leukaemia.

Bhojwani D, Pui CH.

Lancet Oncol. 2013 May;14(6):e205-17. doi: 10.1016/S1470-2045(12)70580-6. Review.

PMID:
23639321
8.

Presence of clone-specific markers at birth in children with acute lymphoblastic leukaemia.

Hjalgrim LL, Madsen HO, Melbye M, Jørgensen P, Christiansen M, Andersen MT, Pallisgaard N, Hokland P, Clausen N, Ryder LP, Schmiegelow K, Hjalgrim H.

Br J Cancer. 2002 Oct 21;87(9):994-9.

9.

The role of anthracyclines in adult acute lymphoblastic leukaemia.

Bassan R, Lerede T, Rambaldi A, Di Bona E, Rossi G, Pogliani E, Lambertenghi-Deliliers G, Porcellini A, Fabris P, Barbui T.

Leukemia. 1996 Jun;10 Suppl 2:s58-61. Review.

PMID:
8649053
10.

Childhood acute lymphoblastic leukaemia--current status and future perspectives.

Pui CH, Campana D, Evans WE.

Lancet Oncol. 2001 Oct;2(10):597-607. Review.

PMID:
11902549
11.

Prognosis in childhood and adult acute lymphoblastic leukaemia: a question of maturation?

Plasschaert SL, Kamps WA, Vellenga E, de Vries EG, de Bont ES.

Cancer Treat Rev. 2004 Feb;30(1):37-51. Review.

PMID:
14766125
12.

Advances in childhood leukaemia: successful clinical-trials research leads to individualised therapy.

Ziegler DS, Dalla Pozza L, Waters KD, Marshall GM.

Med J Aust. 2005 Jan 17;182(2):78-81. Review.

PMID:
15651967
13.

Translocation t(1;19) is related to low cellular drug resistance in childhood acute lymphoblastic leukaemia.

Frost BM, Forestier E, Gustafsson G, Nygren P, Hellebostad M, Jonmundsson G, Kanerva J, Schmiegelow K, Larsson R, Lönnerholm G; Nordic Society for Paediatric Haematology and Oncology.

Leukemia. 2005 Jan;19(1):165-9. No abstract available.

PMID:
15526029
14.

Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy.

Cheok MH, Evans WE.

Nat Rev Cancer. 2006 Feb;6(2):117-29. Review. Erratum in: Nat Rev Cancer. 2006 Mar;6(3):249.

PMID:
16491071
15.

Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia.

Eckert C, Biondi A, Seeger K, Cazzaniga G, Hartmann R, Beyermann B, Pogodda M, Proba J, Henze G.

Lancet. 2001 Oct 13;358(9289):1239-41.

PMID:
11675066
17.

Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohort.

Essig S, Li Q, Chen Y, Hitzler J, Leisenring W, Greenberg M, Sklar C, Hudson MM, Armstrong GT, Krull KR, Neglia JP, Oeffinger KC, Robison LL, Kuehni CE, Yasui Y, Nathan PC.

Lancet Oncol. 2014 Jul;15(8):841-51. doi: 10.1016/S1470-2045(14)70265-7. Epub 2014 Jun 19.

18.

Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region.

Pui CH, Gaynon PS, Boyett JM, Chessells JM, Baruchel A, Kamps W, Silverman LB, Biondi A, Harms DO, Vilmer E, Schrappe M, Camitta B.

Lancet. 2002 Jun 1;359(9321):1909-15.

PMID:
12057554
19.

Pharmacogenomics of acute lymphoblastic leukemia.

Kager L, Evans WE.

Curr Opin Hematol. 2006 Jul;13(4):260-5. Review.

PMID:
16755223
20.

Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.

Ribera JM, Ortega JJ, Oriol A, Granada I, Hernández-Rivas JM, Parody R, Bethencourt C, Rivas C, Bastida P, del Potro E, González-Valentín ME, Moreno MJ, Besalduch J, Fernández-Calvo J, Tormo M, Arias J, Molinés A, Sanz MA, Maldonado J, Millá F, Feliu E, San Miguel JF; PETHEMA Group, Spanish Society of Hematology.

Haematologica. 2002 Feb;87(2):154-66.

Supplemental Content

Support Center